FREE Account Opening + No Clearing Fees
Loading...

Earum IPO vs Sudarshan Pharma IPO

Comparision between Earum IPO and Sudarshan Pharma IPO.

IPO Details

Earum IPO is a SME Fixed Price Issue IPO proposed to list at BSE SME while Sudarshan Pharma IPO is a SME Fixed Price Issue proposed to list at NSE SME.

  Earum IPO Sudarshan Pharma IPO
Logo Earum IPO Logo Sudarshan Pharma IPO Logo
Issue Category SME SME
Issue Type IPO IPO
Process Type Fixed Price Issue Fixed Price Issue
Listing At BSE SME NSE SME
Lead Managers Hem Securities Limited First Overseas Capital Limited
Registrar Bigshare Services Pvt Ltd Kfin Technologies Limited
Market Maker
DRHP DRHP DRHP
RHP RHP RHP
Anchor Investor
IPO Allotment URL IPO Allotment URL

Issue Size and Price

The total issue size of Earum IPO is up to ₹6.65 Cr whereas the issue size of the Sudarshan Pharma IPO is up to ₹24.77 Cr. The final issue price of Earum IPO is ₹36.00 per share and of Sudarshan Pharma IPO is ₹72.00 per share.

  Earum IPO Sudarshan Pharma IPO
Face Value ₹10 per share ₹10 per share
Issue Price (Lower)
Issue Price (Upper)
Issue Price (Final) ₹36.00 per share ₹72.00 per share
Discount (Retail)
Discount (Employee)
Market Lot Size 3000 shares 1600 shares
Fresh Issue Size
Fresh Issue Size (Amount)
OFS Issue Size
OFS Issue Size (Amount)
Issue Size Total 18,48,000 shares 34,40,000 shares
Issue Size Total (Amount) up to ₹6.65 Cr up to ₹24.77 Cr

IPO Timetable

Earum IPO opens on Jun 21, 2019, while Sudarshan Pharma IPO opens on Jun 12, 2019. The closing date of Earum IPO and Sudarshan Pharma IPO is Jun 26, 2019, and Jun 21, 2019, respectively.

  Earum IPO Sudarshan Pharma IPO
Anchor Bid Date
Issue Open Jun 21, 2019 Jun 12, 2019
Issue Close Jun 26, 2019 Jun 21, 2019
Basis Of Allotment (Tentative) Jul 01, 2019 Jun 20, 2019
Initiation of Refunds (Tentative) Jul 02, 2019 Jun 21, 2019
Credit of Share (Tentative) Jul 03, 2019 Jun 24, 2019
Listing date (Tentative) Jul 04, 2019 Jun 25, 2019
Anchor Lockin End date 1 Jul 31, 2019 Jul 20, 2019
Anchor Lockin End date 2 Sep 29, 2019 Sep 18, 2019

Financials

Earum IPO P/E ratio is , as compared to Sudarshan Pharma IPO P/E ratio of .

  Earum IPO Sudarshan Pharma IPO
Financial
Summary of financial Information (Restated)
Particulars For the year/period ended (in Rs. Lakhs)
31-Dec-18 31-Mar-18 31-Dec-17 31-Mar-16
Total Assets 2,741.00 2,052.88 1,108.45 878.71
Total Revenue 3,449.85 3,543.67 2,333.95 1,856.66
Profit After Tax 86.51 85.65 15.98 9.76
Summary of financial Information (Restated)
Particulars For the year/period ended (in Rs. Lakhs)
31-Mar-19 31-Mar-18 31-Mar-17 31-Mar-16
Total Assets 5,013.72 3,096.37 1,992.93 827.24
Total Revenue 14,001.96 8,976.43 5,551.72 3,794.33
Profit After Tax 234.79 73.98 15.63 9.27
Promoter Shareholding (Pre-Issue) 100% 89.29%
Promoter Shareholding (Post-Issue) 70.04% 65.63%
P/E Ratio
Market Cap
ROE
ROCE
Debt/Equity
EPS
RoNW

Shares Offered

In the Earum IPO retail investors (RII) are offered 8,76,000 shares while in Sudarshan Pharma IPO retail investors are offered 8,76,000 shares. Qualified institutional buyers (QIB) are offered in Earum IPO and in Sudarshan Pharma IPO.

  Earum IPO Sudarshan Pharma IPO
Anchor Investor Reserveration
Market Maker Reserveration 96,000 shares 1,76,000 shares
QIB
NII 8,76,000 shares 16,32,000 shares
RII 8,76,000 shares 16,32,000 shares
Employee
Others
Total 17,52,000 shares 32,64,000 shares

Bids Received (Subscription)

Earum IPO subscribed 1.60x in total, whereas Sudarshan Pharma IPO subscribed 0.47x.

  Earum IPO Sudarshan Pharma IPO
QIB (times)
NII (times) 1.72x 0.17x
Big NII (times)
Small NII (times)
RII (times) 1.48x 0.77x
Employee (times)
Other (times)
Total (times) 1.60x 0.47x

Comments

Add a public comment...